Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: A randomized controlled trial

Patient Education and Counseling

Volumn 94, Issue 3, 2014, Pages 356-361

  Zwikker, Hanneke E ^a   Van den Ende, Cornelia H ^a   Van Lankveld, Wim G ^b   Den Broeder, Alfons A ^a   Van den Hoogen, Frank H ^a   Van de Mosselaar, Birgit ^a   Van Dulmen, Sandra ^c,d,e   Van den Bemt, Bart J ^a,d  

^a Sint Maartenskliniek   (Netherlands)

^b HAN UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^c NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

Author keywords

Beliefs about medication; Medication adherence; Motivational interviewing; Randomized controlled trial; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ATTITUDE TO HEALTH; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; PATIENT EDUCATION; PHARMACIST; PSYCHOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVENTION STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; PATIENT EDUCATION AS TOPIC; PHARMACISTS; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 84894079604     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2013.12.002     Document Type: Article

References (56)

1. Blum M.A., Koo D., Doshi J.A. Measurement and rates of persistence with and adherence to biologics for rheumatoid arthritis: a systematic review. Clin Ther 2011, 33:901-913.
2. Brus H., van de Laar M., Taal E., Rasker J., Wiegman O. Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Couns 1999, 36:57-64.
3. Doyle D.V., Perrett D., Foster O.J., Ensor M., Scott D.L. The long-term use of d-penicillamine for treating rheumatoid arthritis: is continuous therapy necessary. Br J Rheumatol 1993, 32:614-617.
4. Koncz T., Pentek M., Brodszky V., Ersek K., Orlewska E., Gulacsi L. Adherence to biologic DMARD therapies in rheumatoid arthritis. Expert Opin Biol Ther 2010, 10:1367-1378.
5. Pullar T., Peaker S., Martin M.F., Bird H.A., Feely M.P. The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy. Br J Rheumatol 1988, 27:381-384.
6. Contreras-Yanez I., Ponce De L.S., Cabiedes J., Rull-Gabayet M., Pascual-Ramos V. Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs. Am J Med Sci 2010, 340:282-290.
7. Van den Bemt B.J.F. Optimizing pharmacotherapy in patients with rheumatoid arthritis: an individualized approach 2009, The Netherlands, Radboud University Nijmegen.
8. Viller F., Guillemin F., Briancon S., Moum T., Suurmeijer T., van den Heuvel W. Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 1999, 26:2114-2122.
9. Haynes R.B., Ackloo E., Sahota N., McDonald H.P., Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev C 2008, 4:CD000011.
10. Brus H.L., van de Laar M.A., Taal E., Rasker J.J., Wiegman O. Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis. Ann Rheum Dis 1998, 57:146-151.
11. Hill J., Bird H., Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis 2001, 60:869-875.
12. Van den Bemt B.J.F., den Broeder A.A., van den Hoogen F.H., Benraad B., Hekster Y.A., van Riel P.L., et al. Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis. Scand J Rheumatol 2011, 40:192-196.
13. Zwikker H., van den Bemt B., van den Ende C., van Lankveld W., den Broeder A., van den Hoogen F., et al. Development and content of a group-based intervention to improve medication adherence in non-adherent patients with rheumatoid arthritis. Patient Educ Couns 2012, 89:143-151.
14. Sabaté E. Adherence to long-term therapies: evidence for action [Internet] 2003, World Health Organization, Switzerland, 209 pp. Available from http://whqlibdoc.who.int/publications/2003/9241545992.pdf [cited 01.11.13].
15. Clifford S., Barber N., Elliott R., Hartley E., Horne R. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci 2006, 28:165-170.
16. Clifford S., Barber N., Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res 2008, 64:41-46.
17. Elliott R.A. Poor adherence to medication in adults with rheumatoid arthritis: reasons and solutions. Dis Manage Health Outcomes 2008, 13-29.
18. Horne R., Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999, 47:555-567.
19. Horne R., Weinman J., Hankins M. The beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999, 1-24.
20. Menckeberg T.T., Bouvy M.L., Bracke M., Kaptein A.A., Leufkens H.G., Raaijmakers J.A., et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res 2008, 64:47-54.
21. Neame R., Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology (Oxford) 2005, 44:762-767.
22. Van den Bemt B.J.F., van den Hoogen F.H., Benraad B., Hekster Y.A., van Riel P.L., van Lankveld W. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol 2009, 36:2164-2170.
23. Moher D., Hopewell S., Schulz K.F., Montori V., Gotzsche P.C., Devereaux P.J., et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 2012, 10:28-55.
24. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62:2569-2581.
25. De Klerk E., van der Heijde D., Landewe R., van der Tempel H., van der Linden S. The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol 2003, 30:2469-2475.
26. Bartholomew L.K., Parcel G.S., Kok G. Intervention mapping: a process for developing theory- and evidence-based health education programs. Health Educ Behav 1998, 25:545-563.
27. Britt E., Hudson S.M., Blampied N.M. Motivational interviewing in health settings: a review. Patient Educ Couns 2004, 53:147-155.
28. Fryling M.J., Wallace M.D., Yassine J.N. Impact of treatment integrity on intervention effectiveness. J Appl Behav Anal 2012, 45:449-453.
29. Lane C., Huws-Thomas M., Hood K., Rollnick S., Edwards K., Robling M. Measuring adaptations of motivational interviewing: the development and validation of the behavior change counseling index (BECCI). Patient Educ Couns 2005, 56:166-173.
30. (assessed 01.10.09). http://www.randomization.com/.
31. Horne R. The Medication Adherence Report Scale (MARS): a new measurement tool for eliciting patients' report non-adherence [Working paper]. Mayfield House, United Kingdom: University of Brighton (accessed 01.01.13).
32. Grijalva C.G., Chung C.P., Arbogast P.G., Stein C.M., Mitchel E.F., Griffin M.R. Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis. Med Care 2007, 45:S66-S76.
33. Fransen J., Langenegger T., Michel B.A., Stucki G. Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. Rheumatology (Oxford) 2000, 39:321-327.
34. Bruce B., Fries J.F. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003, 1:20.
35. Price D.D., Bush F.M., Long S., Harkins S.W. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 1994, 56:217-226.
36. Horne R., Hankins M., Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Qual Health Care 2001, 10:135-140.
37. Evers A.W., Kraaimaat F.W., van Lankveld W., Jongen P.J., Jacobs J.W., Bijlsma J.W. Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psychol 2001, 69:1026-1036.
38. Riemsma R.P., Taal E., Rasker J.J. Group education for patients with rheumatoid arthritis and their partners. Arthritis Rheum 2003, 49:556-566.
39. Lorig K., Chastain R.L., Ung E., Shoor S., Holman H.R. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum 1989, 32:37-44.
40. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
41. Butler J.A., Peveler R.C., Roderick P., Horne R., Mason J.C. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004, 77:786-789.
42. Steiner J.F., Prochazka A.V. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997, 50:105-116.
43. StataCorp LP. Stata longitudinal-data/panel-data reference manual: release 11 2009, Stata Press, College Station, TX, USA.
44. StataCorp LP Stata user's guide: release 11 2009, College Station, TX, USA, Stata Press.
45. Altman D.G. Comparability of randomised groups. The Statistician 1985, 34:125-136.
46. Twisk J.W.R. Applied longitudinal data analysis for epidemiology - a practical guide 2003, Cambridge University Press, Cambridge.
47. Hewitt C.E., Kumaravel B., Dumville J.C., Torgerson D.J. Assessing the impact of attrition in randomized controlled trials. J Clin Epidemiol 2010, 63:1264-1270.
48. Bender B.G., Apter A., Bogen D.K., Dickinson P., Fisher L., Wamboldt F.S., et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. J Am Board Fam Med 2010, 23:159-165.
49. Twisk J.W.R., De Vente W. The analysis of randomised controlled trial data with more than one follow-up measurement. A comparison between different approaches. Eur J Epidemiol 2008, 23:655-660.
50. McNicholas N., Patel A., Chataway J. It is better to be in a clinical trial than not: lessons learnt from clinical neurology - the management of acute multiple sclerosis relapses. QJM 2012, 105:775-780.
51. Gamble J., Stevenson M., Heaney L.G. A study of a multi-level intervention to improve non-adherence in difficult to control asthma. Respir Med 2011, 105:1308-1315.
52. Willey C., Redding C., Staflord J., Garfield F., Geletko S., Flanigan T., et al. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther 2013, 22:858-871.
53. Pasma A., van't Spijker A., Hazes J.M., Busschbach J.J., Luime J.J. Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review. Semin Arthritis Rheum 2013, 43:18-28.
54. Hess L.M., Raebel M.A., Conner D.A., Malone D.C. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006, 40:1280-1288.
55. Pool R., Montgomery C.M., Morar N.S., Mweemba O., Ssali A., Gafos M., et al. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. PLoS ONE 2010, 5:e11600.
56. Zwikker H., van den Bemt B., Vriezekolk J., van den Ende C., Van Dulmen S. Psychosocial predictors of non-adherence to chronic medication: systematic review of longitudinal studies. Patient Preference Adher 2013, [in press].